TAMPA, FL, April 24, 2018 -- MedHOK, Inc., an industry leading platform for healthcare quality and compliance, announced today that Amber Pharmacy successfully launched MedHOK’s Specialty Pharmacy solution.
|
||||||
Amber Pharmacy serves the specialty pharmacy needs of chronically ill patients with long-term, complex treatment needs. Due to the complex nature of chronic conditions, clinical monitoring and intervention are common. Through the use of the MedHOK platform, Amber will automate evidence-based assessments to ensure the efficacy of patient drug regimens to improve adherence and clinical outcomes.
“MedHOK will allow more automation and is fully integrated with our current dispensing platform, increasing efficiency for our users, as well as the quality of care for our patients,” commented Micaila Ruiz, PharmD, R.Ph., Amber chief pharmacy officer.
The clinical component inherent in MedHOK’s Specialty Pharmacy solution integrates with specialty pharmacy dispensing systems, providing full visibility of the order process between systems with as little manual intervention as possible. Visibility, detailed communication between providers and pharmacists, and evidence-based assessments ensure the efficacy of a patient’s drug regimen in the most efficient way possible.
“It is our privilege to serve the needs of Amber Pharmacy’s patient population with the MedHOK platform,” said Gary Stuart, MedHOK president. “We look forward to building a long-term partnership as we work toward the common goal of optimal patient outcomes and value-based care.”
Amber Specialty Pharmacy, with locations in Omaha, NE; Chicago, IL; Dallas, TX; Houston, TX; San Bernardino, CA; and Philadelphia, PA; will roll out the MedHOK Specialty Pharmacy solution across their client base in support of over 18,000 patients.
###
About MedHOK
The mission of MedHOK is to drive better member care in a changing healthcare environment by bringing every care moment across a person’s health journey together through a single technology platform. With a secure, SaaS platform, MedHOK enables federal and state compliance, adherence to quality measures, and enhanced process automation. Clients include Medicare, Medicaid, and commercial health plans, pharmacy benefit managers, specialty pharmacies, and integrated delivery systems. MedHOK has been part of Hearst Health since 2016 and is privately held. For more information, visit www.medhok.com.
About Hearst Health
The Hearst Health network includes FDB (First Databank), Zynx Health, MCG, Homecare Homebase, MedHOK, Hearst Health Ventures and the Hearst Health Innovation Lab (www.hearsthealth.com).Hearst also holds a minority interest in the precision medicine and oncology analytics company M2Gen. The mission of Hearst Health is to help guide the most important care moments by delivering vital information into the hands of everyone who touches a person’s health journey. Each year in the U.S., care guidance from Hearst Health reaches 85 percent of discharged patients, 205 million insured individuals, 70 million home health visits and 3.2 billion dispensed prescriptions.
Attachment
Heather O'Brien, Director of Marketing MedHOK, Inc. (888) 963-3465 ext.1036 [email protected]


Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says
Arm Holdings Q1 Earnings Beat Estimates, Strong Q2 Outlook Fails to Lift ARM Stock
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat
Robinhood Q2 Earnings Beat Estimates, But HOOD Stock Falls as Investors Question Profit Quality
Tesla Weighs China Business Separation Amid SpaceX Merger Speculation
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations
Microsoft Stock Jumps as Azure Growth, AI Revenue Beat Expectations
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness
Chipotle Q2 Earnings Beat Expectations as Sales Growth Drives Higher 2026 Outlook
Colgate-Palmolive Reaffirms 2026 Sales Outlook Despite Weak North America Demand
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger
Russia Charges Telegram Founder Pavel Durov With Facilitating Terrorism, Seeks International Arrest
Starbucks Stock Jumps as Q3 Earnings Beat, Sales Growth Drives Higher 2026 Outlook
Warner Bros. Discovery Shares Rise as Newsom Pushes Settlement in $110 Billion Merger Fight
WestJet Cancels 86 Flights as CUPE Strike Threat Disrupts Travel
Meta Stock Drops After Earnings Miss as AI Spending and Legal Costs Weigh on Profit 



